Ionis stock drops 13% as FDA fails to approve key drug
August 28, 2018 at 10:54 AM EDT
Investors are now wondering whether another, similar Ionis therapeutic, called Tegsedi, will also fail to win approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.